BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 28600598)

  • 1. Recurrence of vocal fold leukoplakia after carbon dioxide laser therapy.
    Chen M; Chen J; Cheng L; Wu H
    Eur Arch Otorhinolaryngol; 2017 Sep; 274(9):3429-3435. PubMed ID: 28600598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for local recurrence of early bilateral vocal cord carcinoma treated with transoral CO
    Tan C; Fang J; Wang R; Zhong Q; Hou L; Ma H; Feng L; He S; Lian M; Yang Y
    Acta Otolaryngol; 2021 Sep; 141(9):860-864. PubMed ID: 34565304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathological parameters associated with histological background and recurrence after surgical intervention of vocal cord leukoplakia.
    Cui W; Xu W; Yang Q; Hu R
    Medicine (Baltimore); 2017 Jun; 96(22):e7033. PubMed ID: 28562558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiolytic laser stripping versus CO2 laser microflap excision for vocal fold leukoplakia: Long-term disease control and voice outcomes.
    Lim JY; Park YM; Kang M; Lee SJ; Baek K; Na J; Choi HS
    PLoS One; 2018; 13(12):e0209691. PubMed ID: 30596718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Variation of Peripheral Inflammatory Markers in Vocal Leukoplakia before and after Recurrence and Canceration.
    Fang Y; Chen M; Yang Y; Chen J; Cheng L; He P; Wu H
    Dis Markers; 2020; 2020():7241785. PubMed ID: 32831972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment outcome of vocal cord leukoplakia by transoral laser microsurgery.
    Yang SW; Chao WC; Lee YS; Chang LC; Hsieh TY; Chen TA; Luo CM
    Lasers Med Sci; 2017 Jan; 32(1):19-27. PubMed ID: 27686889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serial in-office laser treatment of vocal fold leukoplakia: Disease control and voice outcomes.
    Koss SL; Baxter P; Panossian H; Woo P; Pitman MJ
    Laryngoscope; 2017 Jul; 127(7):1644-1651. PubMed ID: 28083976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated peripheral inflammatory markers are related with the recurrence and canceration of vocal fold leukoplakia.
    Fang Y; Yang Y; Chen M; He P; Cheng L; Chen J; Wu H
    Eur Arch Otorhinolaryngol; 2019 Oct; 276(10):2857-2864. PubMed ID: 31367834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical analysis of the application of Diomed-25 laser in treatment of vocal cord leukoplakia in 30 cases].
    Sun G; Zhou S; Wen W; Li Z; Shen X
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2004 Mar; 18(3):141-2. PubMed ID: 15222261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of prognostic factors for vocal fold leukoplakia based on 344 cases at a two-year follow up.
    Yin S; Huang H; Sun P; Zhang D
    J Laryngol Otol; 2023 Oct; 137(10):1170-1175. PubMed ID: 37194075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Feasibility and Associated Limitations of Office-Based Laryngeal Surgery Using Carbon Dioxide Lasers.
    Hu HC; Lin SY; Hung YT; Chang SY
    JAMA Otolaryngol Head Neck Surg; 2017 May; 143(5):485-491. PubMed ID: 28208177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CO2 laser laryngoscopy in a variety of lesions.
    Lyons GD; Lousteau RJ; Mouney DF
    Laryngoscope; 1976 Nov; 86(11):1658-62. PubMed ID: 988464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Positive therapy of andrographolide in vocal fold leukoplakia.
    Xu J; Xue T; Bao Y; Wang DH; Ma BL; Yin CY; Yang GH; Ren G; Lan LJ; Wang JQ; Zhang XL; Zhao YQ
    Am J Otolaryngol; 2014; 35(2):77-84. PubMed ID: 24444776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive factors of recurrence and malignant transformation in vocal cord leukoplakia.
    Lee DH; Yoon TM; Lee JK; Lim SC
    Eur Arch Otorhinolaryngol; 2015 Jul; 272(7):1719-24. PubMed ID: 25749613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical and pathological characteristics of vocal fold leukoplakia and influential factors of recurrence and malignancy].
    Cui WX; Xu W; Yang QW; Cheng LY
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Dec; 30(24):1926-1931. PubMed ID: 29798266
    [No Abstract]   [Full Text] [Related]  

  • 16. A morphological classification for vocal fold leukoplakia.
    Chen M; Li C; Yang Y; Cheng L; Wu H
    Braz J Otorhinolaryngol; 2019; 85(5):588-596. PubMed ID: 30166121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complications and Failures of Office-Based Endoscopic Angiolytic Laser Surgery Treatment.
    Del Signore AG; Shah RN; Gupta N; Altman KW; Woo P
    J Voice; 2016 Nov; 30(6):744-750. PubMed ID: 26433447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Practice variations in voice treatment selection following vocal fold mucosal resection.
    Moore JE; Rathouz PJ; Havlena JA; Zhao Q; Dailey SH; Smith MA; Greenberg CC; Welham NV
    Laryngoscope; 2016 Nov; 126(11):2505-2512. PubMed ID: 26972900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [On microsurgical treatment of vocal cord carcinomas with CO2-laser (author's transl)].
    Burian K; Höfler H
    Laryngol Rhinol Otol (Stuttg); 1979 Jul; 58(7):551-6. PubMed ID: 481035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Laryngoscopic characteristics related to the risk of cancerization of vocal cord leukoplakia.
    Li LJ; Yu Z; Zhu JQ; Wang ML; Li ZX; Yang C; Ni XG
    Acta Otolaryngol; 2021 Aug; 141(8):802-807. PubMed ID: 34314296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.